行情

AMPE

AMPE

Ampio制药
AMEX

实时行情|Nasdaq Last Sale

0.6488
+0.0388
+6.36%
休市 16:00 01/17 EST
开盘
0.6150
昨收
0.6100
最高
0.6631
最低
0.6100
成交量
118.57万
成交额
--
52周最高
1.310
52周最低
0.2600
市值
1.03亿
市盈率(TTM)
-15.0185
分时
5日
1月
3月
1年
5年

分析师评级

2位分析师的综合评级

买入

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

EPS

AMPE 新闻

  • 多国航线避飞两伊 绕远路成本猛涨
  • 新华网.01/11 01:49
  • 雪上加霜!OYO被称将在中国和印度裁员数千人
  • 新浪科技.01/11 01:23
  • 一天狂跌20%不要怕 Jim Cramer :大胆买入!
  • 新浪财经综合.01/11 01:10
  • 美宣布对伊实施新制裁 8名高官和17家矿企在列
  • 新华社.01/11 00:06

更多

所属板块

生物技术和医学研究
-0.16%
制药与医学研究
+0.06%

热门股票

名称
价格
涨跌幅

AMPE 简况

Ampio Pharmaceuticals, Inc. is a biopharmaceutical company. The Company is focused primarily on the development of therapies to treat prevalent inflammatory conditions for which there are limited treatment options. The Company's two lead product candidates in development are Ampion for osteoarthritis of the knee and Optina for diabetic macular edema. Ampion is a sub 5000 molecular weight fraction of commercial human serum albumin (HSA). Optina is a low-dose formulation of danazol. The Ampio segment consists of its biopharmaceuticals compounds and the clinical trials associated with them. The Company is primarily developing compounds that decrease inflammation by inhibiting specific pro-inflammatory compounds by affecting specific pathways at the protein expression and at the transcription level; activating specific phosphatase or depleting available phosphate needed for the inflammation process, and decreasing vascular permeability.
展开

Webull提供Ampio Pharmaceuticals Inc的股票价格,实时市场报价,专业分析师评级,深度图表和免费的股票新闻,以帮助您做出投资决策。